No Data
No Data
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) defied analyst predictions to release its first-quarter results, which were ahead of market expectations. Results clearly exceeded expectations, with a su
Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Aclaris Therapeutics (ACRS) and Immunocore Holdings (IMCR)
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
Express News | Aclaris Therapeutics Shares Fall 5.2% as Q1 Revenue Declines
Earnings Call Summary | Aclaris Therapeutics(ACRS.US) Q1 2024 Earnings Conference
The following is a summary of the Aclaris Therapeutics, Inc. (ACRS) Q1 2024 Earnings Call Transcript:Financial Performance:Aclaris Therapeutics had $161 million in cash, cash equivalents and marketabl
Q1 2024 Aclaris Therapeutics Inc Earnings Call